Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency.

× No keyword cloud information.

13 in total

1. Adenosine deaminase-related growth factors stimulate cell proliferation in Drosophila by depleting extracellular adenosine.

Authors: Michal Zurovec; Tomas Dolezal; Michal Gazi; Eva Pavlova; Peter J Bryant
Journal: Proc Natl Acad Sci U S A Date: 2002-03-19 Impact factor: 11.205

Review 2. Nucleotide-metabolizing enzymes and lymphocyte differentiation.

Authors: R W Barton; I Goldschneider
Journal: Mol Cell Biochem Date: 1979-12-14 Impact factor: 3.396

3. Inhibition of human platelet aggregation and secretion by ant venom and a compound isolated from venom.

Authors: W F Hink; K J Romstedt; J W Burke; R W Doskotch; D R Feller
Journal: Inflammation Date: 1989-04 Impact factor: 4.092

4. Adenosine deaminase gene expression is regulated posttranscriptionally in the nucleus.

Authors: T M Berkvens; F Schoute; H van Ormondt; P Meera Khan; A J van der Eb
Journal: Nucleic Acids Res Date: 1988-04-25 Impact factor: 16.971

5. Localization and identity of adenosine deaminase-positive cells in tissues of the young rat and calf.

Authors: B E Chechik; R Baumal; S Sengupta
Journal: Histochem J Date: 1983-04

6. Sp1 is essential for both enhancer-mediated and basal activation of the TATA-less human adenosine deaminase promoter.

Authors: M R Dusing; D A Wiginton
Journal: Nucleic Acids Res Date: 1994-02-25 Impact factor: 16.971

7. Genetic heterogeneity in partial adenosine deaminase deficiency.

Authors: R Hirschhorn; F Martiniuk; V Roegner-Maniscalco; A Ellenbogen; J L Perignon; T Jenkins
Journal: J Clin Invest Date: 1983-06 Impact factor: 14.808

8. Radioimmunochemical quantitation of human adenosine deaminase.

Authors: P E Daddona; M A Frohman; W N Kelley
Journal: J Clin Invest Date: 1979-09 Impact factor: 14.808

9. Ecto-5'-nucleotidase activity in human T cell subsets. Decreased numbers of ecto-5'-nucleotidase positive cells from both OKT4+ and OKT8+ cells in patients with hypogammaglobulinemia.

Authors: L F Thompson; A Saxon; R D O'Connor; R I Fox
Journal: J Clin Invest Date: 1983-04 Impact factor: 14.808

10. Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID).

Authors: Claire Booth; H Bobby Gaspar
Journal: Biologics Date: 2009-07-13